Medication comparison
Wegovy vs Zepbound: Weight Loss, Dosing & Side Effects
A balanced comparison of FDA-approved weight-management medications semaglutide and tirzepatide.
The short answer
Both are FDA-approved options for adults who meet clinical eligibility. They contain different active ingredients, and the practical choice depends on safety, tolerability, labeled indications, follow-up and coverage.
Wegovy vs Zepbound at a glance
The biggest difference is active ingredient and incretin targets. Milligram amounts across different active ingredients are not equivalent.
| Feature | Wegovy | Zepbound |
|---|---|---|
| Active ingredient | Semaglutide | Tirzepatide |
| Mechanism | GLP-1 receptor agonist | GIP/GLP-1 receptor agonist |
| Weight-management approval | Yes | Yes |
| Typical schedule | Once weekly injection; oral tablet also labeled for certain adult indications | Once weekly injection |
| Common maintenance dose | 1.7 mg or 2.4 mg weekly (injection) | 5 mg, 10 mg or 15 mg weekly |
May be best aligned with
Wegovy
People who may benefit from semaglutide’s labeled indications
- Long-term weight-management indication
- Cardiovascular risk-reduction indication for certain adults
- Semaglutide evidence base
May be best aligned with
Zepbound
People who may benefit from tirzepatide’s dual mechanism
- Dual GIP/GLP-1 mechanism
- Multiple maintenance-dose options
- Sleep apnea indication for certain adults
How the medications work
These medications act on incretin pathways that influence glucose regulation, appetite and digestion. Semaglutide is a GLP-1 receptor agonist. Tirzepatide activates both GIP and GLP-1 receptors. Products with the same active ingredient can still have different FDA-approved indications, devices and dose schedules.
Weight-loss expectations
Clinical-trial averages are useful for understanding a population, not predicting an individual. Results depend on the product, dose reached, treatment duration, starting characteristics, adherence and the trial’s design. Some participants lose more than average, some less, and some stop because of side effects.
Side effects and safety
Common adverse effects include nausea, diarrhea, vomiting, constipation and abdominal discomfort. Product labels also describe less common but serious risks and contraindications. Both semaglutide and tirzepatide product labels include boxed warnings related to thyroid C-cell tumors observed in rodents; the relevance to humans is unknown. Review the current label and your personal and family history with a prescriber.
Cost, savings and insurance
Cash prices, formularies and manufacturer programs change. Coverage often follows the FDA-approved indication: a plan may cover a diabetes product for type 2 diabetes while excluding weight-management medication. Before enrolling in care, confirm the medication price, program fee, laboratory costs, prior-authorization support, renewal fee and cancellation terms.
How clinicians choose
A prescriber may review diagnosis, body-mass index where relevant, weight-related conditions, glucose and kidney measures, gastrointestinal history, pregnancy plans, current medications, prior treatment, eating-disorder history and your ability to follow up. The most effective option on paper is not always the most appropriate or accessible option for one person.
Consider these tradeoffs
- Trial populations and individual responses differ
- Long-term treatment may be needed
- Access may decide the practical choice
Frequently asked questions
Can I take Wegovy and Zepbound together?
No. These medications are not intended to be used together. A licensed clinician should guide any switch and provide individualized timing instructions.
Which has fewer side effects, Wegovy or Zepbound?
Both can cause gastrointestinal effects such as nausea, diarrhea, vomiting, constipation and abdominal discomfort. Individual tolerance varies, and gradual dose escalation may help. Review risks with your prescriber.
Does insurance cover Wegovy or Zepbound?
Coverage depends on the plan, diagnosis, prior-authorization rules and formulary. Confirm benefits directly with the insurer and ask whether a specific indication is excluded.
Sources
Related guidance
Ingredient comparisons
Semaglutide vs Tirzepatide for Weight Loss
Compare two leading incretin medicines across mechanism, approved brands, clinical evidence, dosing and common risks.
14 min read
Muscle preservation
How to Preserve Muscle During GLP-1 Weight Loss
An evidence-informed plan for resistance training, protein, recovery and progress tracking during weight loss.
10 min read
GLP-1 nutrition
Nutrition While Taking a GLP-1 Medication
A balanced framework for protein, fiber, fluids, meal size and changing appetite.
10 min read